Does microalbuminuria predict diabetic nephropathy?

被引：43

作者：

Parving, HH

Chaturvedi, N

Viberti, G

Mogensen, CE

机构：

[1] Steno Diabet Ctr, DK-2820 Gentofte, Denmark

[2] Univ London Imperial Coll Sci & Technol, Sch Med, Dept Epidemiol & Publ Hlth, London, England

[3] Guys & St Thomas Hosp, Div Med, London, England

[4] Aarhus Kommune Hosp, DK-8000 Aarhus, Denmark

来源：

DIABETES CARE | 2002年 / 25卷 / 02期

关键词：

D O I：

10.2337/diacare.25.2.406

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：406 / 407

页数：2

共 18 条

[1] Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria [J].

Ahmad, J ;

Siddiqui, MA ;

Ahmad, H .

DIABETES CARE, 1997, 20 (10) :1576-1581

[2] Reduction of ACE activity is insufficient to decrease microalbuminuria in normotensive patients with type 1 diabetes [J].

Bojestig, M ;

Karlberg, BE ;

Lindström, T ;

Nystrom, FH .

DIABETES CARE, 2001, 24 (05) :919-924

[3] The need for early predictors of diabetic nephropathy risk - Is albumin excretion rate sufficient? [J].

Caramori, ML ;

Fioretto, P ;

Mauer, M .

DIABETES, 2000, 49 (09) :1399-1408

[4] Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria [J].

Chaturvedi, N ;

Stevenson, J ;

Fuller, JH ;

Rottiers, R ;

Ferriss, B ;

Karamanos, B ;

Kofinis, A ;

Petrou, C ;

IonescuTirgovisite, C ;

Iosif, C ;

Tamas, G ;

Bibok, G ;

Kerenyi, Z ;

KisGombos, P ;

Toth, J ;

Grealy, G ;

Priem, H ;

Koivisto, V ;

Tuominen, J ;

Kostamo, E ;

IdziorWalus, B ;

Solnica, B ;

GalickaLatalie, D ;

Michel, G ;

Keipes, M ;

Giuliani, A ;

Herode, A ;

Santeusanio, F ;

Bueti, A ;

Bistoni, S ;

Cagini ;

Navalesi, R ;

Penno, G ;

Nannipieri, M ;

Rizzo, L ;

Miccoli, R ;

Ghirlanda, G ;

Cotroneo, P ;

Manto, A ;

Minella, A ;

Saponara, C ;

Ward, J ;

Plater, M ;

Ibrahim, S ;

Ibbotson, S ;

Mody, C ;

Papazoglou, N ;

Manes, C ;

Soulis, K ;

Voukias, M .

LANCET, 1997, 349 (9068) :1787-1792

[5] Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure [J].

Crepaldi, G ;

Carta, Q ;

Deferrari, G ;

Mangili, R ;

Navalesi, R ;

Santeusanio, F ;

Spalluto, A ;

Vanasia, A ;

Villa, GM ;

Nosadini, R .

DIABETES CARE, 1998, 21 (01) :104-110

[6]

Estacio RO, 2000, DIABETES CARE, V23, pB54

[7] Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria:: the Steno type 2 randomised study [J].

Gæde, P ;

Vedel, P ;

Parving, HH ;

Pedersen, O .

LANCET, 1999, 353 (9153) :617-622

[8]

Gerstein HC, 2000, LANCET, V355, P253

[9] THE BENEFICIAL EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION WITH CAPTOPRIL ON DIABETIC NEPHROPATHY IN NORMOTENSIVE IDDM PATIENTS WITH MICROALBUMINURIA [J].

LAFFEL, LMB ;

MCGILL, JB ;

GANS, DJ .

AMERICAN JOURNAL OF MEDICINE, 1995, 99 (05) :497-504

[10] EFFICACY OF CAPTOPRIL IN POSTPONING NEPHROPATHY IN NORMOTENSIVE INSULIN-DEPENDENT DIABETIC-PATIENTS WITH MICROALBUMINURIA [J].

MATHIESEN, ER ;

HOMMEL, E ;

GIESE, J ;

PARVING, HH .

BMJ-BRITISH MEDICAL JOURNAL, 1991, 303 (6794) :81-87

← 1 2 →